These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7595084)

  • 1. Kinetic evidence for both a fast and a slow secretory pathway for apolipoprotein A-I in humans.
    Fisher WR; Venkatakrishnan V; Zech LA; Hall CM; Kilgore LL; Stacpoole PW; Diffenderfer MR; Friday KE; Sumner AE; Marsh JB
    J Lipid Res; 1995 Jul; 36(7):1618-28. PubMed ID: 7595084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 3H-leucine tracer: its use in kinetic studies of plasma lipoproteins.
    Fisher WR; Venkatakrishnan V; Fisher ES; Stacpoole PW; Zech LA
    Metabolism; 1997 Mar; 46(3):333-42. PubMed ID: 9054478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial HDL deficiency characterized by hypercatabolism of mature apoA-I but not proapoA-I.
    Batal R; Tremblay M; Krimbou L; Mamer O; Davignon J; Genest J; Cohn JS
    Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):655-64. PubMed ID: 9555873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of high density lipoprotein subfractions and constituents in Tangier disease following the infusion of high density lipoproteins.
    Schaefer EJ; Anderson DW; Zech LA; Lindgren FT; Bronzert TB; Rubalcaba EA; Brewer HB
    J Lipid Res; 1981 Feb; 22(2):217-28. PubMed ID: 6787156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein A-I and A-II kinetic parameters as assessed by endogenous labeling with [(2)H(3)]leucine in middle-aged and elderly men and women.
    Velez-Carrasco W; Lichtenstein AH; Li Z; Dolnikowski GG; Lamon-Fava S; Welty FK; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):801-6. PubMed ID: 10712406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of apolipoprotein A-II containing triglyceride rich ApoB lipoproteins in humans.
    Desai NK; Ooi EM; Mitchell PD; Furtado J; Sacks FM
    Atherosclerosis; 2015 Aug; 241(2):326-33. PubMed ID: 26071654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ApoA-II kinetics in humans using endogenous labeling with stable isotopes: slower turnover of apoA-II compared with the exogenous radiotracer method.
    Ikewaki K; Zech LA; Brewer HB; Rader DJ
    J Lipid Res; 1996 Feb; 37(2):399-407. PubMed ID: 9026537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic pathways of apolipoprotein B in heterozygous familial hypercholesterolemia: studies with a [3H]leucine tracer.
    Fisher WR; Zech LA; Kilgore LL; Stacpoole PW
    J Lipid Res; 1991 Nov; 32(11):1823-36. PubMed ID: 1770302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-II.
    Rader DJ; Castro G; Zech LA; Fruchart JC; Brewer HB
    J Lipid Res; 1991 Nov; 32(11):1849-59. PubMed ID: 1770304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human apolipoprotein A-I and A-II metabolism.
    Schaefer EJ; Zech LA; Jenkins LL; Bronzert TJ; Rubalcaba EA; Lindgren FT; Aamodt RL; Brewer HB
    J Lipid Res; 1982 Aug; 23(6):850-62. PubMed ID: 6813411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human apolipoprotein A-I kinetics within triglyceride-rich lipoproteins and high density lipoproteins.
    Vélez-Carrasco W; Lichtenstein AH; Barrett PH; Sun Z; Dolnikowski GG; Welty FK; Schaefer EJ
    J Lipid Res; 1999 Sep; 40(9):1695-700. PubMed ID: 10484617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subjects with ApoA-I(Lys107-->0) exhibit enhanced fractional catabolic rate of ApoA-I in Lp(AI) and ApoA-II in Lp(AI with AII).
    Tilly-Kiesi M; Lichtenstein AH; Ordovas JM; Dolnikowski G; Malmström R; Taskinen MR; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 1997 May; 17(5):873-80. PubMed ID: 9157950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency.
    Ikewaki K; Rader DJ; Sakamoto T; Nishiwaki M; Wakimoto N; Schaefer JR; Ishikawa T; Fairwell T; Zech LA; Nakamura H
    J Clin Invest; 1993 Oct; 92(4):1650-8. PubMed ID: 8408618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular cholesterol efflux. Role of cell membrane kinetic pools and interaction with apolipoproteins AI, AII, and Cs.
    Mahlberg FH; Rothblat GH
    J Biol Chem; 1992 Mar; 267(7):4541-50. PubMed ID: 1537840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-free apolipoproteins A-I and A-II promote remodeling of reconstituted high density lipoproteins and alter their reactivity with lecithin:cholesterol acyltransferase.
    Durbin DM; Jonas A
    J Lipid Res; 1999 Dec; 40(12):2293-302. PubMed ID: 10588955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo metabolism of ApoB, ApoA-I, and VLDL triglycerides in a form of hypobetalipoproteinemia not linked to the ApoB gene.
    Elias N; Patterson BW; Schonfeld G
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1309-15. PubMed ID: 10807747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tangier disease. High density lipoprotein deficiency due to defective metabolism of an abnormal apolipoprotein A-i (ApoA-ITangier).
    Schaefer EJ; Kay LL; Zech LA; Brewer HB
    J Clin Invest; 1982 Nov; 70(5):934-45. PubMed ID: 7130397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of apoA-I kinetics in humans using simultaneous endogenous stable isotope and exogenous radiotracer methods.
    Ikewaki K; Rader DJ; Schaefer JR; Fairwell T; Zech LA; Brewer HB
    J Lipid Res; 1993 Dec; 34(12):2207-15. PubMed ID: 8301239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased production of HDL ApoA-I in homozygous familial defective ApoB-100.
    Schaefer JR; Winkler K; Schweer H; Hoffmann MM; Soufi M; Scharnagl H; Maisch B; Wieland H; Steinmetz A; März W
    Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1796-9. PubMed ID: 10894819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.